| 2022-06-27 | +88.2% | expansion | Seeking Alpha | Acutus climbs 50% as company launches a broader range of cardiac devices |
| 2023-11-08 | -58.3% | expansion | Seeking Alpha | Acutus Medical to cut 65% of workforce, focus on Medtronic contracts |
| 2023-11-08 | -58.3% | earnings | Seeking Alpha | Acutus Medical Non-GAAP EPS of -$0.52 beats by $0.04, revenue of $5.2M beats by $0.36M |
| 2023-11-08 | -58.3% | legal | SEC EDGAR | AFIB 8-K: 2.02, 2.05, 2.06, 5.02, 7.01 (SEC Filing) |
| 2024-05-09 | -55.2% | legal | SEC EDGAR | AFIB 8-K: 2.02 (SEC Filing) |
| 2022-04-27 | +46.9% | legal | SEC EDGAR | AFIB 8-K: 1.01, 7.01 (SEC Filing) |
| 2021-11-12 | -44.9% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2022-11-03 | +30.1% | legal | SEC EDGAR | AFIB 8-K: 8.01 and (SEC Filing) |
| 2023-11-13 | -25.5% | legal | SEC EDGAR | AFIB 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-04-25 | -25.3% | news | Stock Titan | TBIO Stock Price, News & Analysis - Stock Titan |
| 2022-03-30 | -24.7% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2022-07-01 | -23.5% | legal | SEC EDGAR | AFIB 8-K: 1.01, 2.01, 2.03, 3.02, 3.03, 7.01 (SEC Filing) |
| 2024-10-17 | -21.2% | legal | SEC EDGAR | AFIB 8-K: 1.01, 1.02 (SEC Filing) |
| 2021-08-12 | -20.3% | legal | SEC EDGAR | AFIB 8-K: 2.02, 5.02and7.01 (SEC Filing) |
| 2022-12-21 | +18.8% | news | Seeking Alpha | Acutus stock rises as Medtronic to pay $17M milestone under heart device pact |
| 2024-08-09 | -18.6% | earnings | Seeking Alpha | Acutus Medical GAAP EPS of -$0.03, revenue of $4.12M |
| 2023-03-17 | -18.4% | earnings | Seeking Alpha | Acutus Medical, Inc. (AFIB) Q4 2022 Earnings Call Transcript |
| 2023-05-12 | -18.3% | earnings | Seeking Alpha | Acutus Medical, Inc. (AFIB) Q1 2023 Earnings Call Transcript |
| 2024-05-10 | -16.1% | earnings | Seeking Alpha | Acutus Medical GAAP EPS of -$0.06, revenue of $3.6M |
| 2024-11-14 | +16.0% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2022-12-05 | -14.8% | legal | SEC EDGAR | AFIB 8-K: 1.01 and (SEC Filing) |
| 2022-08-12 | -14.8% | earnings | Seeking Alpha | Acutus Medical, Inc. (AFIB) CEO David Roman on Q2 2022 Results - Earnings Call Transcript |
| 2022-11-10 | -13.9% | earnings | Seeking Alpha | Acutus Medical Non-GAAP EPS beats, revenue misses, guidance in-line with consensus |
| 2022-11-10 | -13.9% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2022-07-21 | +13.6% | earnings | Seeking Alpha | Acutus Medical sees Q2 revenue above consensus estimate |
| 2022-07-21 | +13.6% | legal | SEC EDGAR | AFIB 8-K: 2.02, 5.02 (SEC Filing) |
| 2022-05-13 | -12.0% | earnings | Seeking Alpha | Acutus Medical, Inc. (AFIB) CEO Vince Burgess on Q2 2022 Results - Earnings Call Transcript l: ZIP |
| 2023-04-20 | +11.5% | earnings | Seeking Alpha | Acutus Medical reports prelim Q1 results |
| 2023-04-20 | +11.5% | legal | SEC EDGAR | AFIB 8-K: 2.02 (SEC Filing) |
| 2025-03-24 | +11.3% | earnings | Seeking Alpha | Acutus Medical GAAP EPS of -$0.32, revenue of $20.2M |
| 2025-03-24 | +11.3% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2025-01-21 | +10.6% | legal | SEC EDGAR | AFIB 8-K: 1.01, 3.03, 8.01 (SEC Filing) |
| 2022-07-26 | +9.8% | legal | SEC EDGAR | AFIB 8-K: 8.01 and (SEC Filing) |
| 2023-03-24 | -8.8% | news | Seeking Alpha | Acutus Medical (AFIB) Investor Presentation - Slideshow |
| 2023-05-11 | -8.8% | earnings | Seeking Alpha | Acutus Medical GAAP EPS of -$0.57 beats by $0.12, revenue of $4.2M beats by $0.3M |
| 2023-05-11 | -8.8% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2023-01-10 | -8.4% | legal | SEC EDGAR | AFIB 8-K: 8.01 (SEC Filing) |
| 2022-10-18 | +8.2% | legal | Seeking Alpha | Acutus files for FDA approval of catheter ablation system AcQBlate |
| 2024-08-08 | -8.1% | legal | SEC EDGAR | AFIB 8-K: 2.02 (SEC Filing) |
| 2024-12-04 | +7.4% | news | Seeking Alpha | Acutus Medical announces workforce reduction by 70% |
| 2024-12-04 | +7.4% | legal | SEC EDGAR | AFIB 8-K: 2.05, 5.02, 7.01 (SEC Filing) |
| 2023-08-07 | -7.1% | earnings | Seeking Alpha | Acutus Medical Non-GAAP EPS of -$0.60 beats by $0.02, revenue of $5.3M beats by $0.8M |
| 2023-08-07 | -7.1% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2024-01-17 | -6.8% | legal | SEC EDGAR | AFIB 8-K: 5.02 (SEC Filing) |
| 2023-01-09 | -6.6% | earnings | Seeking Alpha | Acutus Medical sees Q4 revenue $4.7M-$4.9M above estimates; appoints Takeo Mukai as CFO |
| 2023-01-09 | -6.6% | legal | SEC EDGAR | AFIB 8-K: 2.02, 5.02 (SEC Filing) |
| 2022-01-19 | -6.6% | legal | SEC EDGAR | AFIB 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-08-22 | -6.4% | legal | SEC EDGAR | AFIB 8-K: 5.02 and (SEC Filing) |
| 2021-06-07 | +6.0% | legal | SEC EDGAR | AFIB 8-K: 1.01 (SEC Filing) |
| 2023-03-13 | -5.7% | legal | SEC EDGAR | AFIB 8-K: 8.01 (SEC Filing) |
| 2024-11-15 | -5.5% | earnings | Seeking Alpha | Acutus Medical GAAP EPS of -$0.03 |
| 2024-11-15 | -5.5% | legal | SEC EDGAR | AFIB 8-K: 1.01 and (SEC Filing) |
| 2022-07-27 | +5.2% | earnings | Seeking Alpha | Acutus' AcQMap system/catheter for irregular heartbeat gets approval in Japan |
| 2024-04-01 | -5.1% | earnings | Seeking Alpha | Acutus Medical GAAP EPS of -$2.81, revenue of $7.2M |
| 2024-04-01 | -5.1% | legal | SEC EDGAR | AFIB 8-K: 2.02 (SEC Filing) |
| 2024-01-11 | -4.3% | legal | SEC EDGAR | AFIB 8-K: 5.02 and (SEC Filing) |
| 2023-08-08 | -4.2% | earnings | Seeking Alpha | Acutus Medical, Inc. (AFIB) Q2 2023 Earnings Call Transcript |
| 2023-08-08 | -4.2% | earnings | Seeking Alpha | Acutus Medical, Inc. 2023 Q2 - Results - Earnings Call Presentation |
| 2021-05-12 | +3.4% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2022-05-12 | -3.2% | legal | SEC EDGAR | AFIB 8-K: 1.01, 2.02, 5.02 (SEC Filing) |
| 2023-01-18 | +3.1% | earnings | Seeking Alpha | Acutus Medical Focuses On Existing Customer Base As Revenue Growth Falters |
| 2023-03-16 | +2.7% | earnings | Seeking Alpha | Acutus Medical GAAP EPS of $0.41 beats by $1.12, revenue of $5M beats by $0.45M |
| 2022-11-13 | -2.2% | earnings | Seeking Alpha | Acutus Medical, Inc. (AFIB) Q3 2022 Earnings Call Transcript |
| 2023-11-14 | +2.1% | earnings | Seeking Alpha | Acutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2M |
| 2021-08-23 | -1.9% | legal | SEC EDGAR | AFIB 8-K: 1.01, 3.02 (SEC Filing) |
| 2022-07-29 | -1.9% | legal | SEC EDGAR | AFIB 8-K: 5.02 and (SEC Filing) |
| 2022-08-11 | +1.4% | earnings | Seeking Alpha | Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M |
| 2022-08-11 | +1.4% | legal | SEC EDGAR | AFIB 8-K: 8.01 and (SEC Filing) |
| 2022-08-11 | +1.4% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |
| 2024-03-05 | -1.0% | legal | SEC EDGAR | AFIB 8-K: 1.01, 2.04, 3.03 (SEC Filing) |
| 2023-07-05 | +0.0% | legal | SEC EDGAR | AFIB 8-K: 5.02 (SEC Filing) |
| 2021-07-12 | -0.0% | legal | SEC EDGAR | AFIB 8-K: 2.02 and (SEC Filing) |